Skip to content
Buy This GLP
← Research
Evidence

Why Do People Start Taking a GLP-1? Health, Then Function

Among 518 adults who had recently started tirzepatide for weight management, health and physical function were common reasons for starting.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team8 min read
Why they startedoverall health83.8%physical function58.3%confidence, appearance51.4%What nearly stopped theminsurance coverage90%cost of treatment57.7%

The PERCEPTIONS study surveyed U.S. adults who had recently started tirzepatide for weight management (n = 518) [1]. Separate interviews about taking GLP-1 drugs explore how people describe living with treatment. This survey focused on reasons for starting and what got in the way.

What made people want to start?

Respondents commonly mentioned health and well-being (83.8%), physical function (58.3%) and confidence or appearance outside work (51.4%). The survey was completed about 26 days after the first dose on average [1].

What got in the way?

Insurance coverage concerned 90% of participants, and medication cost concerned 57.7%. The companion report on employer coverage for obesity medication explores coverage among workers. Both reports describe people who had already started treatment.

Their answers cannot establish how often coverage or cost stops someone from starting treatment.

Frequently asked

What was the most common stated reason?
Improving overall health and well-being was the most frequently reported motivation in the sample.

Sources

  1. [1] Gibble TH, Makin H, Gerber C, Bottomley C, He X, Pisani S, Shepherd M (2026). Understanding reasons for initiation and experience with tirzepatide among individuals with obesity or overweight: Results from the PERCEPTIONS survey Obesity Pillars. PMID 42436850

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence